MEDTRONIC INC
8-A12B, 2000-11-03
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: MEDTRONIC INC, 8-K, 2000-11-03
Next: MEDTRONIC INC, 8-A12B, EX-4, 2000-11-03






                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                            -------------------------

                                    FORM 8-A

                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                     PURSUANT TO SECTION 12(B) OR (G) OF THE
                         SECURITIES EXCHANGE ACT OF 1934



                                 MEDTRONIC, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)



               MINNESOTA                               41-0793183
(STATE OF INCORPORATION OR ORGANIZATION)              (IRS EMPLOYER
                                                 IDENTIFICATION NUMBER)

        7000 CENTRAL AVENUE N.E.                          55432
         MINNEAPOLIS, MINNESOTA                        (ZIP CODE)
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)


   If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box: [X]

   If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), please check the following box: [ ]

      SECURITIES ACT REGISTRATION STATEMENT FILE NUMBER TO WHICH THIS FORM
                                 RELATES: [N/A]


        SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:


                                             NAME OF EACH EXCHANGE ON WHICH
TITLE OF EACH CLASS TO BE SO REGISTERED      EACH CLASS IS TO BE REGISTERED
-----------------------------------------  -------------------------------------
   PREFERRED SHARE PURCHASE RIGHTS               NEW YORK STOCK EXCHANGE

        SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT:

                                     [NONE]
                              (TITLE OF EACH CLASS)



<PAGE>


Item 1.     Description of Securities To Be Registered.
            ------------------------------------------

            On October 26, 2000, the Board of Directors of Medtronic, Inc., a
Minnesota corporation, declared a dividend of one preferred share purchase right
(a "Right") for each outstanding share of common stock, par value $.10 per
share. The dividend is payable on December 1, 2000 to the stockholders of record
at the close of business on December 1, 2000. These rights, which will expire in
2010, will replace preferred share purchase rights that were redeemed effective
as of December 1, 2000 and would have expired by their terms in July 2001.

            Our Board has adopted this Rights Agreement to protect stockholders
from coercive or otherwise unfair takeover tactics. In general terms, it works
by imposing a significant penalty upon any person or group which acquires 15% or
more of our outstanding common stock without the approval of our Board. The
Rights Agreement should not interfere with any merger or other business
combination approved by our Board.

            For those interested in the specific terms of the Rights Agreement
as made between our Company and Wells Fargo Bank Minnesota, N.A., as the Rights
Agent, dated as of October 26, 2000, we provide the following summary
description. Please note, however, that this description is only a summary, and
is not complete, and should be read together with the entire Rights Agreement,
which has been filed as an exhibit to this Registration Statement on Form 8-A. A
copy of the agreement is available free of charge from our Company.

THE RIGHTS. Our Board authorized the issuance of a Right with respect to each
issued and outstanding share of common stock on December 1, 2000. The Rights
will initially trade with, and will be inseparable from, the common stock. The
Rights are evidenced only by certificates that represent shares of common stock.
New Rights will accompany any new shares of common stock we issue after December
1, 2000 until the Distribution Date described below.

EXERCISE PRICE. Each Right will allow its holder to purchase from our Company
one five-thousandth of a share of Series A Junior Participating Preferred Stock
(a "Preferred Share") for $400, once the Rights become exercisable. This portion
of a Preferred Share will give the stockholder approximately the same dividend
and liquidation rights as would one share of common stock. Prior to exercise,
the Right does not give its holder any dividend, voting, or liquidation rights.

EXERCISABILITY.  The Rights will not be exercisable until

-  15 days after the public announcement that a person or group has become an
   "Acquiring Person" by obtaining beneficial ownership of 15% or more of our
   outstanding common stock, or, if earlier,

-  15 business days (or a later date determined by our Board before any person
   or group becomes an Acquiring Person) after a person or group begins a tender
   or exchange offer which, if consummated, would result in that person or group
   becoming an Acquiring Person.

            We refer to the date when the Rights become exercisable as the
"Distribution Date." Until that date, the common stock certificates will also
evidence the Rights, and any transfer of shares of common stock will constitute
a transfer of Rights. After that date, the


                                      -2-


<PAGE>


Rights will separate from the common stock and be evidenced by Rights
certificates that we will mail to all eligible holders of common stock. Any
Rights held by an Acquiring Person are void and may not be exercised.

            Our Board may reduce the threshold at which a person or group
becomes an Acquiring Person from 15% to not less than 10% of the outstanding
common stock.

Consequences of a Person or Group Becoming an Acquiring Person.
--------------------------------------------------------------

-  FLIP IN. If a person or group becomes an Acquiring Person, all holders of
   Rights except the Acquiring Person may, for $400, purchase shares of our
   common stock with a market value of $800, based on the market price of the
   common stock prior to such acquisition.

-  FLIP OVER. If our Company is later acquired in a merger or similar
   transaction after the Rights Distribution Date, all holders of Rights except
   the Acquiring Person may, for $400, purchase shares of the acquiring
   corporation with a market value of $800, based on the market price of the
   acquiring corporation's stock prior to such merger.

Preferred Share Provisions.
--------------------------

Each one five-thousandth of a Preferred Share, if issued:

-  will not be redeemable.

-  will entitle holders to quarterly dividend payments of $.01 per share, or an
   amount equal to the dividend paid on one share of common stock, whichever is
   greater.

-  will entitle holders upon liquidation either to receive $1.00 per share or an
   amount equal to the payment made on one share of common stock, whichever is
   greater.

-  will have the same voting power as one share of common stock.

-  if shares of our common stock are exchanged via merger, consolidation, share
   exchange or a similar transaction, will entitle holders to a per share
   payment equal to the payment made on one share of common stock.

The value of one five-thousandth interest in a Preferred Share should
approximate the value of one share of common stock.

EXPIRATION.  The Rights will expire on October 26, 2010.

REDEMPTION. Our Board may redeem the Rights for one-twentieth of one cent per
Right at any time before any person or group becomes an Acquiring Person. If our
Board redeems any Rights, it must redeem all of the Rights. Once the Rights are
redeemed, the only right of the holders of Rights will be to receive the
redemption price of one-twentieth of one cent per Right. The redemption price
will be adjusted if we have a stock split or stock dividends of our common
stock.



                                      -3-


<PAGE>


EXCHANGE. After a person or group becomes an Acquiring Person, but before an
Acquiring Person owns 50% or more of our outstanding common stock, our Board may
extinguish the Rights by exchanging one share of common stock or an equivalent
security for each Right, other than Rights held by the Acquiring Person.

ANTI-DILUTION PROVISIONS. Our Board may adjust the purchase price of the
Preferred Shares, the number of Preferred Shares issuable and the number of
outstanding Rights to prevent dilution that may occur from a stock dividend, a
stock split, a reclassification of the Preferred Shares or common stock. No
adjustments to the Exercise Price of less than 1% will be made.

AMENDMENTS. The terms of the Rights Agreement may be amended by our Board
without the consent of the holders of the Rights. However, our Board may not
amend the Rights Agreement to lower the threshold at which a person or group
becomes an Acquiring Person to below 10% of our outstanding common stock. In
addition, the Board may not cause a person or group to become an Acquiring
Person by lowering this threshold below the percentage interest that such person
or group already owns. After a person or group becomes an Acquiring Person, our
Board may not amend the agreement in a way that adversely affects holders of the
Rights.

            The Rights Agreement, dated as of October 26, 2000, between the
Company and Wells Fargo Bank Minnesota, N.A., as Rights Agent, specifying the
terms of the Rights is attached hereto as an exhibit and is incorporated herein
by reference. The foregoing description of the Rights is qualified in its
entirety by reference to such exhibit.

Item 2. Exhibits.
        --------

 4.1        Rights Agreement, dated as of October 26, 2000, between
            Medtronic, Inc. and Wells Fargo Bank Minnesota, N.A., which
            includes the form of Right Certificate as Exhibit B and the
            Summary of Rights to Purchase Preferred Shares as Exhibit C.














                                      -4-


<PAGE>


                                    SIGNATURE

            Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the registrant has duly caused this registration statement
to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: October 31, 2000
                                         MEDTRONIC, INC.

                                         By: /s/    David J. Scott
                                             -----------------------------------
                                             Name:  David J. Scott
                                             Title: Senior Vice President and
                                                    General Counsel























                                      -5-


<PAGE>



                                  EXHIBIT LIST



         4.1      Rights Agreement, dated as of October 26, 2000, between
                  Medtronic, Inc. and Wells Fargo Bank Minnesota, N.A., which
                  includes the form of Right Certificate as Exhibit B and the
                  Summary of Rights to Purchase Preferred Shares as Exhibit C.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission